SeaSpine Announces Fourth Quarter and Full-Year 2017 Results and Issues 2018 Financial Guidance

SeaSpine (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2017 and provided guidance for 2018.

As quoted in the press release:

• Revenue of $34.0 million, an increase of 4.5% year-over-year
• U.S. revenue of $31.2 million, an increase of 4.8% year-over-year
  º  U.S. Orthobiologics revenue of $16.6 million, an increase of 10.1% year-over-year
  º  U.S. Spinal Implants revenue of $14.6 million, essentially unchanged year-over-year
• International revenue of $2.8 million, an increase of approximately 1% year-over-year

Click here to read the full press release.